Cancer
Boehringer’s lung cancer candidate enters phase III
August 5, 2009Research and Development, Sales and Marketing Boehringer, Cancer
Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …
Merck Serono asks EMEA to re-think Erbitux rejection
July 30, 2009Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono
Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
BMS launches cancer website
July 15, 2009Medical Communications, Sales and Marketing BMS, Cancer, digi
Bristol-Myers Squibb has launched a new website for sufferers of chronic myeloid leukaemia (CML), a cancer of the blood. MyCMLCare.com …
Pfizer halts Sutent colon cancer trial
July 2, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
Merck Serono breast cancer vaccine enters phase III
June 22, 2009Research and Development Cancer, Merck Serono, Stimuvax, vaccines
Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …
ASCO 2009: advance of the blockbusters
June 18, 2009Sales and Marketing ASCO, Cancer
Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …
Don’t pick on medicines in health service downturn, says ABPI’s Barker
June 18, 2009Research and Development ASCO, Cancer
The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …
Anti-smoking measures boosted by £2.5m grant
June 11, 2009Cancer, NHS
Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …
AstraZeneca and Merck launch early stage trial collaboration
June 3, 2009Research and Development AZ, AstraZeneca, Cancer, Merck
Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …
Avastin fails in colon cancer study
April 30, 2009Research and Development Cancer, Roche
Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
Nexavar fails in melanoma study
April 30, 2009Research and Development Bayer, Cancer, Nexavar
Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
Pfizer halts Sutent head-to-head trial
April 6, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
Survey adds pressure for re-think on bowel cancer drugs
March 24, 2009Medical Communications, Sales and Marketing Cancer
A new survey by Beating Bowel Cancer has highlighted the problems facing patients with the condition in getting the best …
Positive results halt Avastin-Tarceva trial
February 16, 2009Sales and Marketing Cancer, Roche, avastin
A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
